Lexaria Bioscience Corp. Common Stock (LEXX) is a publicly traded Healthcare sector company. As of July 6, 2026, LEXX trades at $0.56 with a market cap of $13.88M and a P/E ratio of 0.00. LEXX moved +0.00% today. Year to date, LEXX is +3.00%; over the trailing twelve months it is -34.51%. Its 52-week range spans $0.46 to $2.85. Rallies surfaces LEXX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for LEXX combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $0.56 |
| Market Cap | $13.88M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.85 |
| 52-Week Low | $0.46 |
| Volume | 8.36K |
| Avg Volume | 0 |
| Revenue (TTM) | $705.92K |
| Net Income | $-11.91M |
| Gross Margin | 99.61% |
LEXX analyst coverage data. Average price target: $0.00.